- Home
- STR vs BCRX Comparison
STR vs BCRX Comparison
Compare STR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STR
- BCRX
- Stock Information
- Founded
- STR 2016
- BCRX 1986
- Country
- STR United States
- BCRX United States
- Employees
- STR N/A
- BCRX N/A
- Industry
- STR Oil & Gas Production
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STR Energy
- BCRX Health Care
- Exchange
- STR Nasdaq
- BCRX Nasdaq
- Market Cap
- STR 1.7B
- BCRX 1.6B
- IPO Year
- STR N/A
- BCRX 1994
- Fundamental
- Price
- STR $18.78
- BCRX $7.51
- Analyst Decision
- STR Buy
- BCRX Strong Buy
- Analyst Count
- STR 6
- BCRX 5
- Target Price
- STR $29.40
- BCRX $15.60
- AVG Volume (30 Days)
- STR 781.5K
- BCRX 2.0M
- Earning Date
- STR 11-06-2024
- BCRX 11-04-2024
- Dividend Yield
- STR 8.00%
- BCRX N/A
- EPS Growth
- STR N/A
- BCRX N/A
- EPS
- STR N/A
- BCRX N/A
- Revenue
- STR $618,668,000.00
- BCRX $412,579,000.00
- Revenue This Year
- STR $4.77
- BCRX $38.01
- Revenue Next Year
- STR N/A
- BCRX $19.04
- P/E Ratio
- STR N/A
- BCRX N/A
- Revenue Growth
- STR 13.74
- BCRX 29.92
- 52 Week Low
- STR $18.58
- BCRX $4.03
- 52 Week High
- STR $25.95
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- STR 17.51
- BCRX 45.56
- Support Level
- STR $21.60
- BCRX $7.15
- Resistance Level
- STR $24.13
- BCRX $7.62
- Average True Range (ATR)
- STR 0.66
- BCRX 0.34
- MACD
- STR -0.42
- BCRX -0.02
- Stochastic Oscillator
- STR 2.19
- BCRX 22.86
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.